SEC Form D · filed November 22, 2021
Starton Therapeutics Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (30)
Keith Darragh · Paramus, NJExecNitin Kaushal · Paramus, NJDirectorPedro Waisman · Paramus, NJExec · DirectorFotios Plakogiannis · Paramus, NJDirectorEric Baum · Paramus, NJDirectorCidnee Vaykovich · Paramus, NJExec · DirectorRoy Waldron · Paramus, NJDirectorMohamad Hussein · Paramus, NJDirectorAsher Chanan-Khan · Paramus, NJDirectorKenneth Anderson · Paramus, NJDirectorRoman Medjanov · San Francisco, CADirectorVor Capital LLP · London, United KingdomDirectorMatthew Dabrowski · Dallas, TXDirectorMaria R. Berkman · Austin, TXDirectorAdam Berman · Austin, TXDirectorChristopher R. Kaster · Austin, TXExecBrian R. Smith · Austin, TXExec · DirectorEileen Tanghal · New York, NYDirectorDavid Helling · Lumberton, TXDirectorJulie Boardman · NEW YORK, NYExec · DirectorStephen Markscheid · Toronto, Ontario, CanadaDirectorJian Yang · Toronto, Ontario, CanadaExec · DirectorStephen Blum · Toronto, Ontario, CanadaExec · DirectorXiangrong Xie · Toronto, Ontario, CanadaExecNicolas Blitterswyk · Toronto, Ontario, CanadaDirectorYun "Wendy" Liu · Toronto, Ontario, CanadaDirectorRobert Van Duynhoven · Toronto, Ontario, CanadaDirectorStephanie Bird · Toronto, Ontario, CanadaDirectorSara Shackelford · Washington, Washington, D.C.DirectorSusan D. Loughran · Glenview, ILDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗